Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 10/2011

01-10-2011 | Original Article

Predictable Factors for Lymph Node Metastasis in Early Gastric Cancer—Analysis of Single Institutional Experience

Authors: Man Sup Lim, Hae-Wan Lee, Hyoungjune Im, Byung Seup Kim, Mi Yeol Lee, Jang Yong Jeon, Dae Hyun Yang, Bong Hwa Lee

Published in: Journal of Gastrointestinal Surgery | Issue 10/2011

Login to get access

Abstract

Introduction

Prediction of lymph node metastasis in early gastric cancer (EGC) is very important to decide treatment strategies preoperatively. The aim of this study was to evaluate factors that predict the presence of lymph node metastasis and to indentify the differences between mucosal and submucosal gastric cancers.

Methods

A total of 376 patients with EGC who underwent gastrectomy from March 1999 through December 2007 were retrospectively identified. The clinopathological factors and biological markers (p53, Ki67) were analyzed.

Results

The rate of lymph node metastasis was 9.6% (mucosal cancer 2.8%, submucosal cancer 18.4%). Tumor size, depth of invasion, macroscopic type, and lymphovascular invasion were related to lymph node metastasis in EGC. When the carcinomas were confined to the mucosal layer, tumor size and lymphovascular invasion showed significant correlation with lymph node metastasis. On the other side, macroscopic type and lymphovascular invasion were association with lymph node metastasis in submucosal carcinoma.

Conclusion

The risk factors for lymph node metastasis in EGC are quite different depending on depth of tumor invasion. To predict lymph node metastasis in EGC, it is recommended that distinct assessment according to individual situation should be clearly established.
Literature
1.
go back to reference Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127–139.PubMedCrossRef Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127–139.PubMedCrossRef
2.
go back to reference Borie F, Millat B, Fingerhut A, Hay JM, Fagniez PL, De Saxce B. Lymphatic involvement in early gastric cancer: prevalence and prognosis in France. Arch Surg 2000;135:1218–1223.PubMedCrossRef Borie F, Millat B, Fingerhut A, Hay JM, Fagniez PL, De Saxce B. Lymphatic involvement in early gastric cancer: prevalence and prognosis in France. Arch Surg 2000;135:1218–1223.PubMedCrossRef
3.
go back to reference Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, Morgagni P, Saragoni L, de Manzoni G, Tomezzoli A. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 2006;94:275–280.PubMedCrossRef Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, Morgagni P, Saragoni L, de Manzoni G, Tomezzoli A. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 2006;94:275–280.PubMedCrossRef
4.
go back to reference Pelz J, Merkel S, Horbach T, Papadopoulos T, Hohenberger W. Determination of nodal status and treatment in early gastric cancer. Eur J Surg Oncol 2004;30:935–941.PubMedCrossRef Pelz J, Merkel S, Horbach T, Papadopoulos T, Hohenberger W. Determination of nodal status and treatment in early gastric cancer. Eur J Surg Oncol 2004;30:935–941.PubMedCrossRef
5.
go back to reference Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. World J Gastroenterol 2004;10:737–740.PubMed Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. World J Gastroenterol 2004;10:737–740.PubMed
6.
go back to reference Hyung WJ, Cheong JH, Kim J, Chen J, Choi SH, Noh SH. Application of minimally invasive treatment for early gastric cancer. J Surg Oncol 2004;85:181–185.PubMedCrossRef Hyung WJ, Cheong JH, Kim J, Chen J, Choi SH, Noh SH. Application of minimally invasive treatment for early gastric cancer. J Surg Oncol 2004;85:181–185.PubMedCrossRef
7.
go back to reference Park DJ, Lee HK, Lee HJ, Lee HS, Kim WH, Yang HK, Lee KU, Choe KJ. Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery. World J Gastroenterol 2004;10:3549–552.PubMed Park DJ, Lee HK, Lee HJ, Lee HS, Kim WH, Yang HK, Lee KU, Choe KJ. Lymph node metastasis in early gastric cancer with submucosal invasion: feasibility of minimally invasive surgery. World J Gastroenterol 2004;10:3549–552.PubMed
8.
go back to reference An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Kim S. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg 2007;246:749–753.PubMedCrossRef An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Kim S. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg 2007;246:749–753.PubMedCrossRef
9.
go back to reference Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003;21:258–270.PubMedCrossRef Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003;21:258–270.PubMedCrossRef
10.
go back to reference Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology 1999;57:131–137.PubMedCrossRef Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K, Aikou T. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology 1999;57:131–137.PubMedCrossRef
11.
go back to reference Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 2010;17:R245-262.PubMedCrossRef Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 2010;17:R245-262.PubMedCrossRef
12.
go back to reference Goishi H, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F. Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep 2000;7:713–18.PubMed Goishi H, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F. Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep 2000;7:713–18.PubMed
13.
go back to reference Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol 1999;6:46–56.PubMedCrossRef Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol 1999;6:46–56.PubMedCrossRef
14.
go back to reference Korean Cancer Center Registry. Ministry of Health and Welfare Republic of Korea. Annual report of Korea Central Cancer Registry 2005. Korean Cancer Center Registry. Ministry of Health and Welfare Republic of Korea. Annual report of Korea Central Cancer Registry 2005.
15.
go back to reference The Information Committee of the Korean Gastric Cancer Association. 2004 Nationwide gastric cancer report in Korea. J Korean Gastric Cancer Assoc 2007;7:47–54. The Information Committee of the Korean Gastric Cancer Association. 2004 Nationwide gastric cancer report in Korea. J Korean Gastric Cancer Assoc 2007;7:47–54.
16.
go back to reference Noh SH, Hyung WJ, Cheong JH. Minimal invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol 2005;90:188–193.PubMedCrossRef Noh SH, Hyung WJ, Cheong JH. Minimal invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol 2005;90:188–193.PubMedCrossRef
17.
go back to reference Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumor. Br J Surg 1992;79:241–244.PubMedCrossRef Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumor. Br J Surg 1992;79:241–244.PubMedCrossRef
18.
go back to reference Adachi Y, Shiraishi N, Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig Surg 2002;19:333–339.PubMedCrossRef Adachi Y, Shiraishi N, Kitano S. Modern treatment of early gastric cancer: review of the Japanese experience. Dig Surg 2002;19:333–339.PubMedCrossRef
19.
go back to reference Okabayashi T, Kobayashi M, Sugimoto T, Okamoto K, Hokimoto N, Araki M. Clinicopathological investigation of early gastric carcinoma; is less invasive surgery right for early gastric carcinoma. Hepatogastroenterology 2007;54:609–612.PubMed Okabayashi T, Kobayashi M, Sugimoto T, Okamoto K, Hokimoto N, Araki M. Clinicopathological investigation of early gastric carcinoma; is less invasive surgery right for early gastric carcinoma. Hepatogastroenterology 2007;54:609–612.PubMed
20.
go back to reference Shen L, Huang Y, Sun M, Xu H, Wei W, Wu W. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single institution experience in China. Can J Gastroenterol 2009;23:353–356.PubMed Shen L, Huang Y, Sun M, Xu H, Wei W, Wu W. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single institution experience in China. Can J Gastroenterol 2009;23:353–356.PubMed
21.
go back to reference Li C, Kim SS, Lai JF, Oh SJ, Hyoung WJ, Choi WH, Choi SH, Zhu ZG, Noh SH. Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol 2008;15:764–769.PubMedCrossRef Li C, Kim SS, Lai JF, Oh SJ, Hyoung WJ, Choi WH, Choi SH, Zhu ZG, Noh SH. Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol 2008;15:764–769.PubMedCrossRef
22.
go back to reference Song SY, Park S, Kim S, Son HJ, Rhee JC. Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease. Histopathology 2004;44:437–444.PubMedCrossRef Song SY, Park S, Kim S, Son HJ, Rhee JC. Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease. Histopathology 2004;44:437–444.PubMedCrossRef
23.
go back to reference Ohashi S, Okamura S, Urano F, Maeda M. Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer. Gastric Cancer 2007;10:241–250.PubMedCrossRef Ohashi S, Okamura S, Urano F, Maeda M. Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer. Gastric Cancer 2007;10:241–250.PubMedCrossRef
24.
go back to reference Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757–4764.PubMed Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757–4764.PubMed
25.
26.
go back to reference Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of cell proliferation-associated human nuclear antibody Ki-67. J Immunol 1984;133:1710–1715.PubMed Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of cell proliferation-associated human nuclear antibody Ki-67. J Immunol 1984;133:1710–1715.PubMed
27.
go back to reference Mita T, Shimoda T. Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol 2001;36:661–668.PubMedCrossRef Mita T, Shimoda T. Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol 2001;36:661–668.PubMedCrossRef
28.
go back to reference Pan W, Ishil H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol 2003;82:104–110.PubMedCrossRef Pan W, Ishil H, Ebihara Y, Gobe G. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol 2003;82:104–110.PubMedCrossRef
Metadata
Title
Predictable Factors for Lymph Node Metastasis in Early Gastric Cancer—Analysis of Single Institutional Experience
Authors
Man Sup Lim
Hae-Wan Lee
Hyoungjune Im
Byung Seup Kim
Mi Yeol Lee
Jang Yong Jeon
Dae Hyun Yang
Bong Hwa Lee
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 10/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1624-5

Other articles of this Issue 10/2011

Journal of Gastrointestinal Surgery 10/2011 Go to the issue